Apollo Endosurgery (APEN) Misses Q3 EPS by 10c

Apollo Endosurgery (NASDAQ: APEN) reported Q3 EPS of ($0.45), $0.10 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $14.1 million versus the consensus estimate of $16.22 million.

For earnings history and earnings-related data on Apollo Endosurgery (APEN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c